nutrafoods-international-journal-logo-80nutrafoods-international-journal-logo-80nutrafoods-international-journal-logo-80nutrafoods-international-journal-logo-80
  • HOME
  • NUTRAFOODS BOARD
  • ARTICLES
  • SUBMIT A MANUSCRIPT
  • CHECK STATUS

Dysglycaemia, diagnosis and treatment

Euglycaemia is characterized by fasting plasma glucose levels of 70–100 mg/dl, while dysglycaemia is characterized by fasting plasma glucose levels of ≥100 mg/dl. The term dysglycaemia covers three conditions: impaired fasting glucose (IFG), impaired carbohydrate tolerance (IGT) and type 2 diabetes mellitus. The identification and classification of dysglycaemia and ways to treat it in order to prevent complications are discussed.

DOI: 10.17470/NF-017-1004-4

DATE: 2017

AUTHOR/S: Derosa G, Maffioli P

ABSTRACT:
Euglycaemia is characterized by fasting plasma glucose levels of 70–100 mg/dl, while dysglycaemia is characterized by fasting plasma glucose levels of ≥100 mg/dl. The term dysglycaemia covers three conditions: impaired fasting glucose (IFG), impaired carbohydrate tolerance (IGT) and type 2 diabetes mellitus. The identification and classification of dysglycaemia and ways to treat it in order to prevent complications are discussed.

KEYWORDS:
Dysglycaemia, Berberis aristata, Ascophyllum nodosum, Fucus vesiculosus, Nutraceutical

 

10.17470/NF-017-1004-4

Download Article

Find a Specific Article

Find by Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016


ISSN 2240-5291 (electronic edition)

EDITORIAL INFORMATION

Editor-in-Chief
Francesco Di Pierro

Journal Office
Anna Lebovich

Mail: info@nutrafoods.eu

Copyright 2019 – Nutrafoods.eu

International Journal on Nutraceuticals, Functional Foods and Novel Foods
- from Research to Industrial Applications -


Privacy Policy  |  Cookies Policy
WebMaster KosmoSol
 
      By continuing to browse the site you are agreeing to our use of cookies.